ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline ACN Q1 2026 Earnings EPS Beats Estimates by 213 Amid Consulting Demand OUT Q1 2026 Earnings EPS Surprise Positive Amidst Market Headwinds ASRV Q1 2026 Earnings Stable EPS at 011 Amidst Flat Market Response SSTK Q4 2025 Earnings EPS Misses Estimates as Growth Headwinds Persist HWBK Q1 2026 Earnings Strong EPS Performance Amid No Revenue Guidance